NIH-funded research R03 grant

Understanding how bacteria protect themselves from viruses using CRISPR technology

Official title: Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems

Funded at University of Oklahoma · NIH-11000346 · Data updated 2026-11-12

This study looks at how certain bacteria use a special immune system to fight off viruses, and by understanding how they remember past infections, we hope to find new ways to help treat tough bacterial infections that don't respond to antibiotics.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Oklahoma
NIH-funded
Lab location1 site (Norman, United States)
Project startDecember 12, 2023
Project endOctober 31, 2025
Funding year2025
Award (this year)$70,990
NIH project number5R03AI175981-02
Project IDNIH-11000346 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals suffering from infections caused by antibiotic-resistant bacteria.

Less likely to help

Patients with viral infections that are not bacterial in nature may not receive any benefit from this research.

What this research studies

This research investigates how certain bacteria use a unique immune system called CRISPR-Cas to defend against viral infections. By examining the mechanisms that allow bacteria to remember past infections and adapt their defenses, the study aims to uncover the specific processes involved in this immune response. The research focuses on the type II-A CRISPR systems, which have distinct properties that could lead to new biotechnological applications. Patients may benefit from advancements in treating antibiotic-resistant bacterial infections through improved understanding of these mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for combating antibiotic-resistant bacterial infections.

How similar studies have gone: Previous research has shown promise in understanding CRISPR mechanisms, indicating potential for success in this area of investigation.

Where this research is happening

  • University of Oklahoma
    Norman, United States
    Active

Researchers

  • Principal investigator: Rajan, Rakhi — University of Oklahoma
  • Study coordinator: Rajan, Rakhi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.